medigraphic.com
SPANISH

Dermatología Cosmética, Médica y Quirúrgica

Órgano oficial de la Sociedad Mexicana de Cirugía Dermatológica y Oncológica, AC
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2023, Number 4

<< Back Next >>

Dermatología Cosmética, Médica y Quirúrgica 2023; 21 (4)

Nail involvement in pediatric patients with epidermolysis bullosa occurs in all disease subtypes

Pastrana AE, Morales OD, García RMT
Full text How to cite this article

Language: English
References: 13
Page: 296-299
PDF size: 178.83 Kb.


Key words:

epidermolysis bullosa, nail disease, nails malformed, pediatrics.

ABSTRACT

Introduction: ungual alterations are extremely frequent in patients with epidermolysis bullosa (EB) and may even be associated with prognosis and outcomes. However, there are few studies characterizing nail involvement in EB.
Methods: we performed an observational cross-sectional descriptive study of children aged zero to 18 years with the diagnosis of EB cared for at the National Institute for Pediatrics, a tertiary referral center in Mexico City.
Results: we searched for nail involvement in 22 patients with EB (14 with recessive dystrophic EB, four with dominant dystrophic EB, two with EB simplex, one with junctional EB and one with Kindler syndrome) that attended our specialized multidisciplinary clinic. Patients had a median age of 9.2 years (range 0.4-17.5), and all had nail involvement. The most frequent nail changes across all subtypes were: anonychia (81.8%), hypotrophic/dystrophic nails (31.8%), pachyonychia (22.7%) and longitudinal ridging (4.5%).
Discussion/conclusion: we found all patients had nail alterations regardless of EB subtypes. Most of those with severe subtypes had anonychia at a young age. This descriptive study confirms nail changes are extremely frequent in all subtypes of EB. Further studies to characterize nail involvement in specific subtypes of EB and association with outcomes are needed.


REFERENCES

  1. Fine JD, Epidemiology of inherited epidermolysis bullosa basedon incidence and prevalence estimates from the National EpidermolysisBullosa Registry, jama Dermatol 2016; 152(11):1231-8.

  2. Fine JD, Bruckner-Tuderman L, Eady R, Bauer EA, Bauer JW,Has C et al., Inherited epidermolysis bullosa: updated recommendationson diagnosis and classification, J Am Acad Dermatol2014; 70(6):1103-26.

  3. Fine JD, Eady RA, Bauer EA, Bauer JW, Bruckner-Tuderman L,Heagerty A et al., The classification of inherited epidermolysisbullosa (eb): report of the Third International Consensus Meetingon Diagnosis and Classification of eb, J Am Acad Dermatol2008; 58(6): 931-50.

  4. Tosti A, De Farias DC and Murrell DF Nail involvement in epidermolysisbullosa, Dermatol Clin 2010; 28(1):153-7.

  5. Bruckner-Tuderman L, Schnyder UW and Baran R, Nail changesin epidermolysis bullosa: clinical and pathogenetic considerations,Br J Dermatol 1995; 132(3):339-44.

  6. González-Cantero A, Sánchez-Moya AI, Pérez-Hortet C, Martínez-Lorenzo E, Gómez-Dorado B and Schoendorff-Ortega C,“Nails only” phenotype and partial dominance of p.Glu170Lysmutation in a family with epidermolysis bullosa simplex, PediatrDermatol 2017; 34(4):e205-6.

  7. Moss C, Wong A and Davies P, The Birmingham epidermolysisbullosa severity score: development and validation, Br J Dermatol2009; 160(5):1057-65.

  8. Rogers, M, Nail manifestations of some important genetic disordersin children, Dermatol Ther 2002, 15(2):111-20.

  9. Pruneddu S, Castiglia D, Floriddia G, Cottoni F and Zambruno G,col7a1 recessive mutations in two siblings with distinct subtypesof dystrophic epidermolysis bullosa: pruriginosa versusnails only, Dermatology 2011; 222(1):10-4.

  10. Horn HM and Tidman MJ, The clinical spectrum of epidemolysisbullosa simplex, Br J Dermatol 2000; 142:468-72.

  11. Sato-Matsumura KC, Yasukawa K, Tomita Y and Shimizu H, Toenaildystrophy with col7a1 glycine substitution mutations segregatesas an autosomal dominant trait in 2 families with dystrophicepidermolysis bullosa, Arch Dermatol 2002; 138(2):269-71.

  12. Dharma B, Moss C, McGrath JA, Mellerio JE and Ilchyshyn A,Dominant dystrophic epidermolysis bullosa presenting as familialnail dystrophy, Clin Exp Dermatol 2001; 26(1):93-6.

  13. Nath AK, Chougule A and Thappa DM, Long cuticle of the nail inKindler’s syndrome: is it more than an incidental finding?, IndianJ Dermatol Venereol Leprol 2009; 75(3):314-5.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Dermatología Cosmética, Médica y Quirúrgica. 2023;21